THERAPEUTIKA

Patent europeic · EP2144905 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2144905
Numer da la dumonda
EP08742520
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
03-04-2008
Publitgà
20-01-2010
Concedì
28-11-2012
Stritgà
30-04-2018
Motiv
Taxa annuala betg pajada
Classas IPC
C07D 417/12 (2006.01)
A61K 31/428 (2006.01)
A61P 25/18 (2006.01)
A61P 25/22 (2006.01)
A61P 25/28 (2006.01)
Prioritad
US 921759 P 04.04.2007
Dumonda PCT
PCT/US2008/004336 03.04.2008
Publicaziun PCT
WO2008/124030 16.10.2008
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 21-11-2018

    Stritgà, taxa betg pajada

    Published in Swissreg on 21.11.2018

  2. 08-06-2017

    Transferì

    Owner
    Merck Sharp & Dohme Corp., 126 East Lincoln Avenue, Rahway, NJ 07065-0907, USA → Merck Sharp & Dohme Corp., 126 East Lincoln Avenue, Rahway, NJ 07065-0907, USA, Sumitomo Dainippon Pharma Co., Ltd., 6-8, Dosho-machi 2-chome, Chuo-ku, Osaka-shi, Osaka 541-8524, Japan

    Published in Swissreg on 08.06.2017

  3. 22-01-2013

    Represchentant inscrit

    Representative
    Marks & Clerk (Luxembourg) LLP, Dreikönigstrasse 31a, 8002 Zürich

    Published in Swissreg on 22.01.2013

  4. 28-11-2012

    Concedì

    Published in Swissreg on 28.11.2012

Partidas

Inventur

BILODEAU, Mark, T.

Rahway, New Jersey 07065-0907, US

NANDA, Kausik, K.

Rahway, New Jersey 07065-0907, US

TROTTER, B. Wesley

Rahway, New Jersey 07065-0907, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.